Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754754 · ClinicalTrials.gov registry record · NA
Brain Retraction Monitoring Sensor Study
A NA study of Brain Surgery Requiring Significant Retraction of the Brain, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 3
- Study locations
NCT00754754: Completed NA study of Brain Surgery Requiring Significant Retraction of the Brain, sponsored by Vanderbilt University.
NCT00754754 is a NA study of Brain Surgery Requiring Significant Retraction of the Brain that has completed, run by Vanderbilt University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00754754, a NA study of Brain Surgery Requiring Significant Retraction of the Brain, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to utilize a sensor incorporated into a brain retractor blade to monitor electrical activity and pressure applied to the brain during retraction required for the selected skull base operations. The overall goal of the study is to develop a protocol and guidelines to prevent the development of brain retraction injury during neurosurgical procedures requiring significant retraction.
Conditions Studied
Interventions
- PROCEDURE Brain Retraction Monitoring Sensor
Study Locations (3)
Indiana
- Methodist Hospital - Indianapolis
Tennessee
- Vanderbilt University Medical Center - Nashville
Virginia
- Inova Fairfax Hospital - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT00754754 record still lists
NCT00754754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Brain Surgery Requiring Significant Retraction of the Brain appearing as the primary indexed condition, and to 1 intervention - of which Brain Retraction Monitoring Sensor is the first listed.
NCT00754754 reports a single indexed study location in Indiana, Tennessee, Virginia.
Frequently Asked Questions
What is clinical trial NCT00754754 about?
NCT00754754 is a clinical study titled "Brain Retraction Monitoring Sensor Study". The purpose of this study is to utilize a sensor incorporated into a brain retractor blade to monitor electrical activity and pressure applied to the brain during retraction required for the selected skull base operations. The overall goal of the study is to develop a protocol and guidelines to prev...
What is the current status of trial NCT00754754?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2008-09. Estimated completion is 2011-06.
What conditions does trial NCT00754754 study?
This clinical trial studies the following conditions: Brain Surgery Requiring Significant Retraction of the Brain.
What interventions are being tested in trial NCT00754754?
The interventions under investigation include: Brain Retraction Monitoring Sensor (PROCEDURE).
Who is sponsoring clinical trial NCT00754754?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00754754 being conducted?
This trial has 3 study locations across Indiana, Tennessee, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00754754's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia